{"success":true,"data":{"pressRelease":{"id":"170348","rtpr_id":"nPnd4Zm9a-20261015","ticker":"CAI","exchange":"NASDAQ","all_tickers":["CAI"],"title":"Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026","author":"PR Newswire","published_at":"2026-10-15T12:30:01.286Z","article_body":"Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026\nPR Newswire\n\nIRVING, Texas, Oct. 15, 2026\n\nIRVING, Texas, Oct. 15, 2026 /PRNewswire/ -- Caris Life Sciences\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798485-1&h=2160010237&u=https%3A%2F%2Fwww.carislifesciences.com%2F&a=Caris+Life+Sciences)\n(®) (NASDAQ: CAI), a leading TechBio company, today announced it will report\nthird quarter 2026 financial results on Wednesday, November 4, 2026.\n\nCaris Life Sciences will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to\ndiscuss the financial results.\n\nWebcast Details:\n\nDate: Wednesday, November 4, 2026\nTime: 3:30 p.m. CT (4:30 p.m. ET)\nLive Webcast: https://edge.media-server.com/mmc/p/nri9afky\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798485-1&h=3838073225&u=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fnri9afky&a=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fnri9afky)\n\nA replay of the webcast will be available shortly after the conclusion of the\ncall on the Investor Relations section of the Caris Life Sciences website at\nCarisLifeSciences.com.\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798485-1&h=2423891979&u=https%3A%2F%2Finvestor.carislifesciences.com%2F&a=CarisLifeSciences.com.)\n\nAbout Caris Life Sciences\nCaris Life Sciences(®) (Caris) is a leading TechBio company actively\ndeveloping and commercializing innovative solutions to transform healthcare.\nThrough comprehensive molecular profiling (Whole Genome, Whole Exome and Whole\nTranscriptome Sequencing), advanced AI and machine learning, Caris has created\nthe large-scale, multimodal clinico-genomic database and computing capability\nneeded to analyze and further unravel the molecular complexity of disease.\nThis convergence of next-generation sequencing, AI and machine learning\ntechnologies and high-performance computing provides a differentiated platform\nfor developing the latest generation of advanced precision medicine diagnostic\nsolutions for early detection, diagnosis, monitoring, therapy selection and\ndrug development.\n\nCaris was founded with a vision to realize the potential of precision medicine\nto improve the human condition. Headquartered in Irving, Texas, Caris has\noffices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel,\nSwitzerland. Caris or its distributor partners provide services in the U.S.\nand other international markets.\n\nCaris Life Sciences Media:\nCorporate Communications\nCorpComm@CarisLS.com (mailto:CorpComm@CarisLS.com)\n214.294.5606\n\nInvestor Relations:\nIR@CarisLS.com (mailto:IR@CarisLS.com)\n917.689.3511\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-third-quarter-2026-financial-results-on-november-4-2026-302909332.html\n(https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-third-quarter-2026-financial-results-on-november-4-2026-302909332.html)\n\nSOURCE Caris Life Sciences\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS863020/Caris-Life-Sciences-Logo.jpg?id=OA3020258\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnd4Zm9a-20261015","title":"Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026","author":"PR Newswire","ticker":"CAI","created":"2026-10-15T12:30:01.286Z","tickers":["CAI"],"exchange":"NASDAQ","article_body":"Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026\nPR Newswire\n\nIRVING, Texas, Oct. 15, 2026\n\nIRVING, Texas, Oct. 15, 2026 /PRNewswire/ -- Caris Life Sciences\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798485-1&h=2160010237&u=https%3A%2F%2Fwww.carislifesciences.com%2F&a=Caris+Life+Sciences)\n(®) (NASDAQ: CAI), a leading TechBio company, today announced it will report\nthird quarter 2026 financial results on Wednesday, November 4, 2026.\n\nCaris Life Sciences will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to\ndiscuss the financial results.\n\nWebcast Details:\n\nDate: Wednesday, November 4, 2026\nTime: 3:30 p.m. CT (4:30 p.m. ET)\nLive Webcast: https://edge.media-server.com/mmc/p/nri9afky\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798485-1&h=3838073225&u=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fnri9afky&a=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fnri9afky)\n\nA replay of the webcast will be available shortly after the conclusion of the\ncall on the Investor Relations section of the Caris Life Sciences website at\nCarisLifeSciences.com.\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798485-1&h=2423891979&u=https%3A%2F%2Finvestor.carislifesciences.com%2F&a=CarisLifeSciences.com.)\n\nAbout Caris Life Sciences\nCaris Life Sciences(®) (Caris) is a leading TechBio company actively\ndeveloping and commercializing innovative solutions to transform healthcare.\nThrough comprehensive molecular profiling (Whole Genome, Whole Exome and Whole\nTranscriptome Sequencing), advanced AI and machine learning, Caris has created\nthe large-scale, multimodal clinico-genomic database and computing capability\nneeded to analyze and further unravel the molecular complexity of disease.\nThis convergence of next-generation sequencing, AI and machine learning\ntechnologies and high-performance computing provides a differentiated platform\nfor developing the latest generation of advanced precision medicine diagnostic\nsolutions for early detection, diagnosis, monitoring, therapy selection and\ndrug development.\n\nCaris was founded with a vision to realize the potential of precision medicine\nto improve the human condition. Headquartered in Irving, Texas, Caris has\noffices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel,\nSwitzerland. Caris or its distributor partners provide services in the U.S.\nand other international markets.\n\nCaris Life Sciences Media:\nCorporate Communications\nCorpComm@CarisLS.com (mailto:CorpComm@CarisLS.com)\n214.294.5606\n\nInvestor Relations:\nIR@CarisLS.com (mailto:IR@CarisLS.com)\n917.689.3511\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-third-quarter-2026-financial-results-on-november-4-2026-302909332.html\n(https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-third-quarter-2026-financial-results-on-november-4-2026-302909332.html)\n\nSOURCE Caris Life Sciences\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS863020/Caris-Life-Sciences-Logo.jpg?id=OA3020258\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-15T12:30:01.727497333Z","server_sent_at_ms":1792067401727},"received_at":"2026-10-15T12:30:01.778Z","source_url":"https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-third-quarter-2026-financial-results-on-november-4-2026-302909332.html"},"analysis":{"id":"158531","press_release_id":"170348","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Caris Life Sciences (NASDAQ: CAI) announced it will report third quarter 2026 financial results on Wednesday, November 4, 2026.\n\nThe company will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the results, with a replay available on its investor relations website.\n\nThis is a scheduling notice only; no results or guidance are included.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Calendar item: Caris Life Sciences Q3 2026 earnings call set for November 4, 2026."},"keyFigures":{},"namedEntities":{"people":[],"products":[],"companies":[{"name":"Caris Life Sciences","ticker":"CAI"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"This is a routine earnings-date/webcast scheduling notice with no financial results or guidance. No new information beyond the date and time of the Q3 call."},"tickerRelevance":{"others":[],"primary":"CAI"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"earnings-date-notice","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Caris Life Sciences (NASDAQ: CAI) announced it will report third quarter 2026 financial results on Wednesday, November 4, 2026.\n\nThe company will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the results, with a replay available on its investor relations website.\n\nThis is a scheduling notice only; no results or guidance are included.","key_figures":{},"named_entities":{"people":[],"products":[],"companies":[{"name":"Caris Life Sciences","ticker":"CAI"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-15T12:30:18.251Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap","eventGravity":"earnings-date-notice","issuerAuthored":true}},"durationMs":3294,"modelName":"glm-5.3-flashx"}}